{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:02:30Z","timestamp":1791820950967,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T00:00:00Z","timestamp":1491955200000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jacc.2015.12.068","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T13:37:00Z","timestamp":1458567420000},"page":"1661-1671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of\u00a0Aspirin Dose in Patients Requiring Dual\u00a0Antiplatelet Therapy"],"prefix":"10.1016","volume":"67","author":[{"given":"Muthiah","family":"Vaduganathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron L.","family":"Cryer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hua","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheorghe","family":"Doros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Lanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Schnitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Shook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Lapuerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Laine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2015.12.068_bib1","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2015.12.068_bib2","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.CIR.0000091201.39590.CB","article-title":"Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study","volume":"108","author":"Peters","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.12.068_bib3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-150-6-200903170-00006","article-title":"Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding","volume":"150","author":"Steinhubl","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2015.12.068_bib4","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","volume":"58","author":"Smith","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.068_bib5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.111.047498","article-title":"Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"124","author":"Mahaffey","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.12.068_bib6","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"52","author":"Bhatt","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.068_bib7","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1093\/eurheartj\/ehp256","article-title":"Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT trial","volume":"30","author":"Moukarbel","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.12.068_bib8","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.amjcard.2013.05.051","article-title":"Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United Kingdom primary care","volume":"112","author":"Martin Merino","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.12.068_bib9","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.068_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/apt.13260","article-title":"The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial","volume":"42","author":"Vardi","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jacc.2015.12.068_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003044","article-title":"Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care","volume":"3","author":"de Jong","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2015.12.068_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1572-0241.2002.05419.x","article-title":"Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy","volume":"97","author":"Rabeneck","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacc.2015.12.068_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0895-4356(00)00365-6","article-title":"SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health","volume":"54","author":"Rabeneck","year":"2001","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jacc.2015.12.068_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.amjcard.2009.10.014","article-title":"Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)","volume":"105","author":"Cannon","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.12.068_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/CIRCOUTCOMES.113.000822","article-title":"Contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States: results from the National Cardiovascular Data Registry (NCDR)","volume":"7","author":"Hall","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2015.12.068_bib16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"McQuaid","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2015.12.068_bib17","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","article-title":"Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis","volume":"321","author":"Derry","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2015.12.068_bib18","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.amjcard.2005.06.011","article-title":"Bleeding complications related to aspirin dose","volume":"96","author":"Laine","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.12.068_bib19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"363","author":"Mehta","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.068_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/M15-1460","article-title":"The\u00a0ADAPTABLE trial and PCORnet: shining light on a new research paradigm","volume":"163","author":"Hernandez","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2015.12.068_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding","volume":"352","author":"Chan","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.068_bib22","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.068_bib23","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2010.09.010","volume":"56","author":"Abraham","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.068_bib24","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archinte.168.15.1684","article-title":"Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention","volume":"168","author":"Saini","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2015.12.068_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3949\/ccjm.77a.09173","article-title":"Omeprazole and clopidogrel: should clinicians be worried?","volume":"77","author":"Depta","year":"2010","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jacc.2015.12.068_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/CIRCULATIONAHA.111.019745","article-title":"Antiplatelet therapy and proton pump inhibition: clinician update","volume":"125","author":"Moukarbel","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.12.068_bib27","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.amjcard.2010.10.073","article-title":"Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention","volume":"107","author":"Banerjee","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.12.068_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.112.117283","article-title":"Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin","volume":"127","author":"Grosser","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.12.068_bib29","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.STR.0000231683.43347.ec","article-title":"Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers","volume":"37","author":"Cox","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2015.12.068_bib30","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(96)01254-8","article-title":"Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product","volume":"348","author":"Kelly","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.12.068_bib31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ajg.2010.436","article-title":"Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial","volume":"106","author":"Cryer","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacc.2015.12.068_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ahj.2014.05.017","article-title":"PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies","volume":"168","author":"Whellan","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2015.12.068_bib33","doi-asserted-by":"crossref","first-page":"e003208","DOI":"10.1161\/CIRCINTERVENTIONS.115.003208","article-title":"Revisiting the clopidogrel-proton pump inhibitor interaction: from bench to bedside","volume":"8","author":"Vaduganathan","year":"2015","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716003983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716003983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T02:43:45Z","timestamp":1656729825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109716003983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":33,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0735109716003983"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2015.12.068","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of\u00a0Aspirin Dose in Patients Requiring Dual\u00a0Antiplatelet Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2015.12.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}